Ocugen, Inc

+$0.52 (+6.32%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Ocugen, Inc and other stocks, options, and ETFs commission-free!

About OCGN

Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline includes OCU400, OCU410, OCU200, and COVAXIN.

CEO
Shankar Musunuri
Employees
15
Headquarters
Malvern, Pennsylvania
Founded
2013

OCGN Key Statistics

Market Cap
2.09B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
107.78M
High Today
$8.80
Low Today
$8.02
Open Price
$8.26
Volume
42.02M
52 Week High
$18.77
52 Week Low
$0.17

OCGN News

Financial TimesMay 11

Wm Morrison hints at cash return for shareholders after a ‘good start’ to the year

TipRanks Ocugen (OCGN) has been a 2021 success story, as the eye disease specialist has decided to moonlight in the lucrative world of coronavirus stocks. The

OCGN Earnings

-$3.55
-$2.07
-$0.59
$0.89
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
-$0.04 per share
Replay Earnings Call

You May Also Like

MOSY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure